Hypoxia is a prominent feature of malignant tumors that are characterized by angiogenesis and vascular hyperpermeability. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) has been shown to be up-regulated in the vicinity of necrotic tumor areas, and hypoxia potently induces VPF/VEGF expression in several tumor cell lines in vitro. Here we report that hypoxia-induced VPF/VEGF expression is mediated by increased transcription and mRNA stability in human M21 melanoma cells. RNAbinding/electrophoretic mobility shift assays identified a single 125-bp AU-rich element in the 3Ј untranslated region that formed hypoxia-inducible RNA-protein complexes. Hypoxia-induced expression of chimeric luciferase reporter constructs containing this 125-bp AU-rich hypoxia stability region were significantly higher than constructs containing an adjacent 3Ј untranslated region element without RNA-binding activity. Using UV-cross-linking studies, we have identified a series of hypoxia-induced proteins of 90/88 kDa, 72 kDa, 60 kDa, 56 kDa, and 46 kDa that bound to the hypoxia stability region element. The 90/88-kDa and 60-kDa species were specifically competed by excess hypoxia stability region RNA. Thus, increased VPF/VEGF mRNA stability induced by hypoxia is mediated, at least in part, by specific interactions between a defined mRNA stability sequence in the 3Ј untranslated region and distinct mRNA-binding proteins in human tumor cells.
INTRODUCTION
Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) 1 is a potent activator of microvascular permeability in vivo and an endothelial cell-specific mitogen in vitro Ferrara and Henzel, 1989; Gospodarowicz et al., 1989; Keck et al., 1989; Leung et al., 1989; Levy et al., 1989; Conn et al., 1990; Senger et al., 1990; Ferrara et al., 1991a,b; Dvorak et al., 1992) . VPF/VEGF expression has been closely associated with the pathological angiogenesis observed in malignant tumors (Plate et al., 1992; Brown et al., 1993a,b; Weindel et al., 1994; Brown et al., 1995a,b) , diabetic retinopathy (Adamis et al., 1994; Aiello et al., 1994) , retinopathy of prematurity Pierce et al., 1995; Stone et al., 1995) , rheumatoid arthritis (Fava et al., 1994) , and coronary artery disease (Sabri et al., 1991; Ladoux and Frelin, 1993; Hashimoto et al., 1994) . Tissue hypoxia is a common feature in many of these diseases and VPF/VEGF expression is dramatically up-regulated in human solid tumors adjacent to sites of focal necrosis (Plate et al., 1992; Shweiki et al., 1992; Brown et al., 1993) .
Hypoxia-stimulated VPF/VEGF expression has been attributed to increases in both transcriptional and posttranscriptional mechanisms (Ikeda et al., 1995; Stein et al., 1995; Levy et al., 1996a,b) . The transcriptional up-regulation of VPF/VEGF under hypoxia appears to be a common mechanism in a multitude of tumor cell types and has been linked to 5Ј flanking elements of the VPF/VEGF gene that contain binding sites for the hypoxia-regulated transcription factor, hypoxia-inducible factor 1 (Wang and Semenza, 1993; Minchenko et al., 1994; Levy et al., 1995; Liu et al., 1995) . Hypoxia has also been shown to increase VPF/ VEGF mRNA stability in several rodent and human cell lines (Ikeda et al., 1995; Mukhopadhyay et al., 1995; Shima et al., 1995; Stein et al., 1995; Levy et al., 1996a,b) . VPF/VEGF belongs to a group of genes with labile mRNAs, including c-fos, c-myc, and granulocyte-macrophage colony-stimulating factor (GM-CSF) (Schuler and Cole, 1988; Brewer, 1991; Vakalopoulou et al., 1991; You et al., 1992; Chen and Shyu, 1995) . Many of these mRNAs possess adenylate-uridylate-rich elements (AREs) in their 3Ј untranslated regions (3Ј UTR), which are thought to regulate mRNA stability (Chen and Shyu, 1995) . These labile mRNAs have been shown to be transiently stabilized by various stimuli including phorbol ester, calcium ionophore, cyclic adenosine monophosphate, and tumor necrosis factor-␣ (Malter and Hong, 1991; Stephens and Bauerle, 1992) .
Recently, a family of proteins has been described that bind to the consensus AUUUA sequence, which is frequently present in the AREs of labile mRNAs. These proteins, which range from 15 to 40 kDa, include AU-binding factor 1 (Brewer, 1991; Zhang et al., 1993) , AU-A/Band/C (Bohjanen et al., 1991 (Bohjanen et al., , 1992 Katz et al., 1994) , AU-binding factor (Gillis and Malter, 1991; Malter and Hong, 1991) , AU-binding protein (Nagy and Rigby, 1995) , AUH and enoyl CoA-hydratase isoform (Nakagawa et al., 1995) , interleukin 1 mRNAbinding protein (Gorospe and Baglioni, 1994) , GM-CSF/c-myc/c-fos mRNA-binding protein (Shaw and Kamen, 1986; Malter, 1989; Vakalopoulou et al., 1991; You et al., 1992) , and surprisingly, glyceraldehyde-3-phosphate dehydrogenase (Nagy and Rigby, 1995) . This plethora of binding proteins may play a critical role in modulating the rate of degradation of distinct mRNAs that contain AREs.
Recently, it has been reported that the half-life of rat VPF/VEGF mRNA was regulated by both stabilizing and destabilizing AREs in the 3Ј UTR (Levy et al., 1996) . In addition, hypoxia-inducible proteins of apparent molecular weights of 17,000, 28,000, and 32,000 have been identified that bind to the 3Ј UTR (Levy et al., 1996) .
Because hypoxia-induced VPF/VEGF expression plays an important role in promoting tumor angiogenesis and progression of several human malignant tumors, we sought to characterize the mechanisms that mediate hypoxia-induced VPF/VEGF expression in human tumor cells. In particular, the contribution of VPF/VEGF mRNA stability and its role in promoting hypoxia-induced VPF/VEGF expression was examined. Here we report the identification of elements in the 3Ј UTR of the human VPF/VEGF mRNA that bind to hypoxia-induced proteins, the role of these elements in hypoxia-mediated mRNA accumulation, and the partial characterization of the RNA-binding proteins involved.
MATERIALS AND METHODS

Cell Lines, Culture Conditions, and Transfection Procedures
The human melanoma cell line M21 was obtained from Dr. Romaine Saxton (University of California, Los Angeles, CA). Cells were cultured in DMEM supplemented with 10% fetal bovine serum, 2 mM l-glutamine, 10 U/ml penicillin, and 10 g/ml streptomycin. Normoxic cell cultures were maintained in a humidified Queue (Asheville, NC) incubator in an atmosphere of 5% CO 2 , 21% O 2 , and 74% N 2 at 37°C. Hypoxia experiments were performed for the indicated times in a humidified triple gas Heraeus model 6060 incubator (Hanau, Germany) calibrated to deliver 5% CO 2 , 2% O 2 , and 93% N 2 at 37°C. Cells were transfected with the calcium phosphate method as described previously . Cell extracts were made with passive lysis buffer and luciferase assays were performed with a Luciferase Assay kit (Promega, Madison, WI). Total-cell RNA was isolated and analyzed for VPF/VEGF mRNA expression by Northern blot analysis as outlined below. VPF/VEGF secretion was analyzed by a human VPF/VEGF enzyme-linked immunosorbent assay (R&D Systems, Minneapolis, MN).
RNA Isolation and Northern Blot Analysis
Total cellular RNA was isolated from cultured cell lines using Trizol reagent (Life Technologies, Gaithersburg, MD) according to the manufacturer's instructions. Northern blot analyses were performed as described previously . VPF/VEGF 165 hybridization probe was an AccI-NcoI fragment (823 bp) encompassing the coding region and 330 bp of 3Ј UTR of the FL cDNA clone (see below). A ribosome-associated protein cDNA, 36B4, was used as a control (Masiakowski et al., 1983) . Probes were prepared by the [␣- 32 P]dCTP random-primed synthesis method using the Multiprime kit (Amersham, Arlington Heights, IL). Blots were washed at high stringency (1% SDS, 0.1ϫ SSC at 60°C), exposed to x-ray film (Kodak X-Omat AR, Eastman Kodak, Rochester, NY) for up to 24 h, and subjected to phosphorimage quantification (Molecular Dynamics, Sunnyvale, CA).
Cloning, Sequencing, Subcloning, and Analysis of Human VPF/VEGF 165 cDNA A partial human VPF/VEGF cDNA clone was isolated by reverse transcription-polymerase chain reaction (PCR) amplification using human VPF/VEGF sequence-specific primers. The partial PCR product of approximately 300 bp was sequenced and used as a probe to obtain the FL clones by screening a cDNA library prepared from normal human mammary epithelial cells (76N ZAP library, Stratagene, La Jolla, CA) (Lee et al., 1991) . Approximately 10 5 recombinant phages (2-4 ϫ 10 3 per 150-mm dish) were transferred in duplicate to nitrocellulose filters and hybridized overnight at highstringency conditions. The longest cDNA clones obtained by library screening were excised and ligated into pBluescript vectors (Stratagene) and were further characterized and sequenced by the dideoxy chain termination sequencing method (Sequenase kit version 2.0, United States Biochemical, Cleveland, OH). A 3.6-kb complete cDNA encoding the VPF/VEGF 165 amino acid isoform was isolated and sequenced and contained 701 bp of 5Ј UTR and 1.9 kb of 3Ј UTR (GenBank access no. AF022375). The coding sequence was in complete agreement with the VPF/VEGF 165 sequence described previously (Tischer et al., 1991) . A subclone of the FL cDNA was made that deleted the entire 5Ј UTR and coding region and maintained untranslated sequences from 219 bp to 1890 bp downstream of the stop codon. Oligonucleotide primer pairs used for PCR amplification of 3Ј UTR sequences were: 3Ј hypoxia stability region (3Ј HSR) sense 5Ј-TAGACACACCCACCCACATA-3Ј and antisense 5Ј-AACATTAGCACTGTTAATT-3Ј; 3Ј control region 1 (3Ј CR-1) sense 5Ј-GATGTATGTGACTGCTGTGG-3Ј and antisense 5Ј-CATGC-CCTGGCCTTGCACATTC-3Ј; and 3Ј control region 2 (3Ј CR-2) sense 5Ј-GTGCAAGGCCAGGGCATGGG-3Ј and antisense 5Ј-GTC-CTGAAGCTCCCCAAACTCC-3Ј. Amplified PCR products were ligated into pCR-Script vector (Stratagene) according to the manufacturer's instructions and sequenced to confirm identity to the original.
Transcription Run-Off Assays
M21 and U373 cells were incubated for 24 h under normoxic or hypoxic conditions. Five ϫ 100-mm dishes (approximately 1 ϫ 10 7 cells) were washed twice with ice-cold phosphate-buffered saline, lysed by adding 0.5 ml per dish of lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM NaCl, 3 mM MgCl 2 , 0.35% sucrose, and 0.5% Nonidet P-40), and scraped into microfuge tubes and placed on ice for 5 min. Nuclei were pelleted for 3 min at 500 ϫ g. The supernatant was removed and the pellets were carefully resuspended in 0.5 ml of lysis buffer and recentrifuged for 3 min at 500 ϫ g. Nuclei were suspended in 50 l of glycerol storage buffer (50 mM Tris-HCl, pH 8.3, 5 mM MgCl 2 , 300 mM KCl, 10 mM EDTA, and 40% glycerol), snap frozen in liquid nitrogen, and stored at Ϫ80°C. For run-off transcription reactions, frozen nuclei were thawed on ice and centrifuged at 100 ϫ g for 2 min. Pelleted nuclei were resuspended in 50 l of reaction buffer [5 mM Tris-HCl, pH 8.0, 2.5 mM MgCl 2 , 150 mM KCl, 0.5 mM rNTP [A,G,C], 0.7 M rUTP, 2.5 mM dithiothreitol, and 5 U RNAsin (Promega)]. After addition of 100 Ci [␣-32 P]UTP (Ͼ3000 Ci/mmol), the suspended nuclei were incubated at 30°C for 23 min and mixed every 5 min to prevent clumping. Transcription was terminated and total RNA was isolated by the addition of 40 g of glycogen carrier and 0.8 ml of Trizol reagent. Chloroform was added and phases were separated by centrifugation at 14,000 ϫ g for 10 min at 4°C. Supernatants were extracted with phenol/chloroform, precipitated with 0.5 volume of isopropanol, and RNA/glycogen pellets were washed with 100% ice-cold ethanol. The radiolabeled RNA pellets were resuspended in 0.05 ml of diethyl pyrocarbonate-treated water containing 10 mM ␤-mercaptoethanol, and an aliquot was counted by liquid scintillation counting.
Slot blots used for RNA hybridizations were made with 5 g of hVPF/VEGF, hGlut-1, 36B4, and 2.5 g of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNAs denatured with 100 mM NaOH at 100°C for 10 min, neutralized with NH 4 OAc to 1 M final concentration, and directly blotted onto Biotrans (New England Nuclear, Boston, MA) nylon membranes (ICN, Costa Mesa, CA) using a vacuum slot blot apparatus (Schleicher & Schuell, Keene, NH). Membranes were subsequently washed twice with 2ϫ SSC and baked at 80°C for 1 h. Blots were prehybridized for 6 h at 65°C in hybridization buffer (50 mM peperazine-n, NЈ-bis(2-ethanesulfonic acid), pH 6.5, 50 mM sodium phosphate mono/dibasic, pH 7.0, 20 mM NaCl, 5% SDS, 2.5 mM EDTA, and 50 g/ml of denatured salmon sperm DNA). Hybridizations were performed with equal amounts of labeled nuclear RNA at 1 ϫ 10 6 dpm/ml of hybridization buffer for 20 h at 65°C. Blots were then washed twice at room temperature for 20 min and once at 55°C for 20 min in 1.0% SDS-1ϫ SSC. Blots were exposed for 2 d to x-ray film (Kodak X-Omat AR) and subjected to phosphorimage analysis (Molecular Dynamics).
Determination of VPF/VEGF mRNA Half-Life in Cultured Cells
Cells were grown under normoxic or hypoxic conditions in complete media containing 10% fetal bovine serum for 20 h before the addition of actinomycin D at 5 g/ml. Cells were returned to normoxic or hypoxic incubators for the indicated time before rapid RNA isolation. Total RNA (10 g) was analyzed by Northern blot as outlined above, and only the mature VPF/VEGF mRNA signal (4.2 kb) was quantified by phosphorimage analysis. The VPF/VEGF mRNA signal was normalized to the 28S ribosomal signal. Least squares regression analysis of the resulting line was performed (Kaleidagraph, Synergy Software, Reading, PA), and half-life values were determined from the regression curves.
RNA-binding/Electrophoretic Mobility Shift Assay (EMSA)
Cells were grown under normoxic or hypoxic conditions, and cytoplasmic extracts were prepared at 4°C with slight modifications of the method described previously (Wang et al., 1995) . Briefly, cells were washed three times in ice-cold phosphate-buffered saline and then lysed with 0.5 ml per 100-mm dish of lysis buffer [50 mM HEPES, pH 7.5, 10 mM sodium pyrophosphate, 150 mM NaCl, 100 mM NaF, 0.2 mM NaOVa 4 , 1 mM EGTA, 1.5 mM MgCl 2 , 1% Triton X-100, 10% glycerol, 5 mM 4-(2-aminoethyl)benzene-sulfonyl fluoride, and 3 g/ml of aprotinin, leupeptin, and soybean trypsin inhibitor]. Cells were collected with a cell lifter, mixed well by pipetting, and placed into microcentrifuge tubes. The tubes were incubated on ice for 10 min, centrifuged at 14,000 ϫ g for 10 min, and supernatants were frozen in liquid nitrogen and stored at Ϫ80°C. Protein concentrations were determined using the Bio-Rad DC reagent assay (Bio-Rad, Hercules, CA).
RNA transcripts were synthesized from linearized DNA templates using either T3 or T7 bacteriophage RNA polymerases with the RNA Transcription kit (Stratagene) according to the manufacturer's instructions. Transcription reactions were treated with RNase-free DNase (Promega) for 15 min at 37°C, were extracted once with phenol/chloroform, and free ribonucleotides were removed using RNase-free G-50 spin columns (Boehringer Mannheim, Indianapolis, IN). Radiolabeled RNAs were analyzed for complete transcription by denaturing sequencing gels and were quantitated by liquid scintillation counting. Nonradioactive RNAs were evaluated by agarose gel electrophoresis and ethidium bromide staining to quantify relative amounts using RNA markers (Life Technologies) as standards.
Radiolabeled RNA transcripts (200,000 cpm/reaction) were combined with protein extract (30 g) in binding buffer for a final concentration of 10 mM HEPES (pH 7.5), 5 mM MgCl 2 , 50 mM KCl, 0.5 mM EGTA, 0.5 mM dithiothrietol, 10% glycerol, 100 g/ml tRNA, and 5 mg/ml heparin. The reaction mixture was incubated at 30°C for 20 min. Ribonuclease T1 (40 units) (Boehringer Mannheim) alone or in combination with 1 g of ribonuclease A (Boehringer Mannheim) was added and incubated for 15 min at room temperature. The reaction mixtures were electrophoresed for 2 h in a 4% native polyacrylamide gel in 0.5ϫ Tris borate EDTA buffer. Gels were dried and exposed to x-ray film, and RNA complexes were quantified by phosphorimage analysis.
UV-cross-linking studies were performed by UV-cross-linking RNA-binding reactions in a Stratalinker (Stratagene) for 10 min (total energy ϭ 1800 J/cm 2 ). Ribonuclease T1 (40 units) and A (1 g) were then added and incubated at room temperature for 15 min before the addition of SDS sample buffer containing reducing agent (10 mM Tris-HCl, pH 6.8, 100 mM dithiothrietol, 0.15% SDS, 10% glycerol, and 0.05% bromophenol blue). The samples were boiled for 5 min before electrophoresis on a 10% acrylamide SDS-polyacrylamide gel.
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RESULTS
Hypoxia-induced VPF/VEGF mRNA Expression in M21 Melanoma Cells Is Mediated by Increased Transcription and mRNA Stability
A human M21 melanoma tumor cell line was selected for study of the regulation of VPF/VEGF expression by hypoxia. Treatment of M21 cells with hypoxia over a time course of 32 h revealed a maximal VPF/VEGF expression at 12-16 h ( Figure 1A ). Prolonged hypoxia (Ͼ32 h) resulted in cell death as determined by cell detachment from plates. Hypoxia induction of steadystate VPF/VEGF mRNA expression in M21 cells was maximally up-regulated at 16 h by 6.5-fold ( Figure  1B) . The enhanced mRNA expression resulted in a comparable increase in VPF/VEGF secretion with maximal secretion rates between 8 and 16 h as determined by an enzyme-linked immunosorbent assay ( Figure 1C ). In contrast, the expression of the ribosome-associated protein mRNA, 36B4, was not affected by hypoxia.
To more clearly define the cellular mechanisms controlling the induction of VPF/VEGF mRNA expression in these tumor cell lines, the regulation of transcription and mRNA stability were investigated separately. To analyze transcriptional control, run-off transcription assays were performed that showed a 2.7-fold up-regulation of VPF/VEGF mRNA transcription by hypoxia in M21 cells compared with the 36B4 control, which was unaffected (Figure 2A ). In comparison, GAPDH showed a 3-fold and Glut-1 a 2.5-fold transcription up-regulation, consistent with the increased hypoxic expression of both of these genes (Graven et al., 1994; Ebert et al., 1995) . The level of increased gene transcription, however, only partially accounted for the total increase in VPF/VEGF mRNA expression observed by Northern blot analysis, suggesting an additional effect of hypoxia on mRNA stability.
To examine the effect of hypoxia on the stability of VPF/VEGF mRNA, M21 cells were treated with the transcriptional inhibitor actinomycin D in the presence or absence of hypoxia. The rate of decay of the mature VPF/VEGF mRNA (4.2 kb) was determined by Northern blot hybridization over a 3-h treatment period ( Figure 2B ). In the example shown, hypoxic conditions significantly increased the half-life of VPF/ VEGF mRNA from 1.6 to 2.75 h. A similar experiment performed in triplicate revealed a t 1/2 for VPF/VEGF mRNA of 1.47 Ϯ 0.15 h for normoxia and 2.62 Ϯ 0.13 h for hypoxia. This induction was statistically significant using Student's t test at p ϭ 0.0005, which is considered extremely significant. Thus, a 1.8-fold increase in mRNA stability was observed in the M21 cells along with a 2.75-fold increase in transcription, yielding the approximate 6-to 7-fold increase observed in the steady-state mRNA level. These data indicated that increased mRNA stability significantly contributes to the total hypoxia-induced VPF/VEGF expression in M21 cells.
Cloning and Sequence of a Human VPF/VEGF 165 FL cDNA Containing the Complete 3 UTR
Although the transcriptional regulation of the VPF/ VEGF gene is thought to be mediated through 5Ј flanking gene sequences containing binding sites for the transcription factor, hypoxia-inducible factor 1, the mechanisms regulating mRNA stability of human VPF/VEGF have not been characterized in detail. To evaluate VPF/VEGF mRNA sequences for potential interaction with cellular RNA-binding proteins affecting mRNA stability, a human FL VPF/VEGF 165 cDNA was cloned from a human breast epithelial cell library. The cDNA clone contained 0.7 kb of the estimated 1.1-kb 5Ј UTR described previously (Tischer et al., 1991) , the coding region of 573 bp, and a 1.9-kb 3Ј UTR. The 3Ј UTR has been identified in several genes as the location of mRNA stabilizing or destabilizing elements. The sequence of the human VPF/VEGF 3Ј UTR and key potential mRNA regulatory sites are shown in Figure 3A . The 3Ј UTR sequence extends from one base after the TGA stop codon to 1890 bp and contains two consensus AAUAAA polyadenylation sites within the 3Ј UTR at 388 bp and 1626 bp. Two complete consensus sequences for the mRNA destabilizing elements 5Ј-UUAUUUA(U/A)(U/A)-3Ј (Lagnado et al., 1994; Zubiaga et al., 1995) were localized at 1231 bp and 1734 bp in the 3Ј UTR. Several studies suggested that multiple copies of the AUUUA base sequence might affect mRNA stability (Chen and Shyu, 1995) , and five AUUUA sequences were located within the 3Ј UTR. Four AU-rich elements were present in pairs, grouped between 358 and 425 bp (AU 1 and AU 2) and between 1549 and 1598 bp (AU 3 and AU 4). A CU-rich sequence, described as a potential site for binding proteins that bind to the tyrosine hydroxylase mRNA (Czyzyk-Krzeska et al., 1994a,b; Czyzyk-Krzeska and Beresh, 1996) was located between 1343 bp and 1358 bp.
An AU-rich Sequence in the 3 UTR of the Human VPF/VEGF mRNA Mediates Hypoxia-inducible Protein Binding
To further characterize hypoxia-induced VPF/VEGF mRNA stability in M21 melanoma cells, protein-binding studies with radiolabeled mRNAs transcribed from the VPF/VEGF 165 cDNA template were performed using RNA binding and EMSAs. RNA transcripts ( Figure 3B ) that covered the FL VPF/VEGF 165 Figure 2 . Hypoxia-induced VPF/VEGF transcription and mRNA stability in M21 melanoma cells. (A) Transcription run-off assay of M21 cells exposed to 24 h normoxic (N) or hypoxic (H) conditions. Total radiolabeled RNAs were hybridized to denatured cDNA templates encoding GAPDH, VPF/VEGF, Glut-1, and 36B4. Fold induction by quantification is indicated. (B) Representative Northern blot analysis of M21 cells preincubated for 20 h under normoxic or hypoxic conditions. Actinomycin D was added at time 0 and total RNA was isolated after up to 3 h. Mature VPF/VEGF mRNA signal and 36B4 control are indicated by arrows. VPF/VEGF mRNA decay curves and mRNA half-life (t 1/2 ) are presented below each Northern blot.
Hypoxia Regulation VPF/VEGF mRNA Stability Vol. 9, February 1998 mRNA sequence [full length (FL)], the 5Ј UTR and [coding region (CR)] (5Ј ϩ CR), the 5Ј UTR only (5Ј UTR), or the 3Ј UTR only (3Ј UTR) were used as probes for binding studies. As shown in Figure 4A , several RNA-protein complexes were detected when the FL or the 3Ј UTR transcripts were used as probes, but not with the 5Ј ϩ CR or the 5Ј UTR. RNase T1 treatment of the 3Ј UTR alone revealed a RNase 
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Molecular Biology of the CellT1-resistant sequence independent of protein binding. Pretreatment of cell extracts with proteinase or by boiling completely eliminated the binding activity, suggesting that the complexes observed were likely RNA-protein complexes. Antisense transcripts from FL or 3Ј UTR sequences did not form RNA-protein complexes, indicating that complex formation was sense-orientation dependent. These data suggested that RNA-binding activity was restricted to the 3Ј UTR of the VPF/VEGF mRNA.
When RNA binding/EMSA was performed using two 3Ј UTR transcripts of 0.5-kb and 1.5-kb in length (3Ј 0.5 kb and 3Ј 1.5 kb, see Figure 3B ), RNA-protein complexes were readily formed using both the 3Ј 1.5-kb and the 3Ј 0.5-kb transcripts with normoxic extracts and an increased amount in hypoxic M21 cell extracts ( Figure 4B ), indicating that the predominant protein-binding element was localized between 219 bp and 768 bp of the VPF/VEGF 3Ј UTR.
To further narrow down the 3Ј UTR sequence involved in the formation of hypoxia-induced RNAprotein complexes, three subfragments of the 3Ј 0.5-kb sequence were obtained by PCR and subcloned into transcription vectors (see MATERIALS AND METH-ODS). When RNA binding/EMSA was performed with these subfragments of 3Ј 0.5 kb using both RNase T1 and RNase A to completely digest RNase T1-resistant sequences, the 3Ј HSR but not the 3Ј CR-1 (control region 1) or CR-2 (control region 2) formed protein complexes. M21 melanoma cell extracts demonstrated two different mobility shift bands ( Figure 5A ) binding to the 3Ј HSR. In response to hypoxia, the lower band was increased two-to threefold, whereas the upper band was decreased. Antisense RNA transcripts did not show any binding activity, indicating sequence specificity in the sense orientation.
When the RNA binding/EMSA with normoxic M21 cell extracts binding to the 3Ј HSR probe was performed in the presence of a 50-fold mass excess of either 3Ј HSR RNA in the sense and antisense orientation or the 3Ј 0.5-kb RNA, only the sense orientation 3Ј HSR and 3Ј 0.5-kb RNAs competed for binding. Similar competition experiments performed with 3Ј CR-1 and 3Ј CR-2 transcripts showed no competition with RNA-protein complexes. Thus, the 3Ј HSR sequence, which contains two AU-rich elements (AU 1 and AU 2), is a highly specific element for hypoxiaregulated RNA-binding proteins, suggesting that this region potentially regulates mRNA stability through these RNA-binding proteins.
VPF/VEGF 3 HSR Element Has a Stem Loop Secondary Structure
Because the 125-bp 3Ј HSR sequence showed hypoxia-induced RNA-protein complexes in M21 cells, the importance of secondary structure that might be required for protein recognition was investigated by performing an RNA-folding algorithm, MUFOLD (Jaeger et al., 1989a,b; Zuker, 1989) . The resulting secondary folding pattern (Figure 6 ) incorporates the two AU-rich regions (AU 1 and AU 2) in a stem loop configuration. The folding energy of the stem loop formed by just the AU 1 and AU 2 regions was Ϫ28.4 Kcal/mol and Ϫ16.5 Kcal/mol for the entire 3Ј HSR region. The potential for stem loop protein recognition by RNA-binding proteins has already been established in other systems such as the iron regulatory element-binding proteins (Aziz and Munro, 1987) . To evaluate whether VPF/VEGF mRNA elements can promote gene expression by increasing mRNA stability, we designed luciferase-VPF/VEGF mRNA chimeric constructs under the control of a constitutive cytomegalovirus enhancer/promoter (see Figure 7A ). The constructs have VPF/VEGF cDNA sequences consisting of the whole 3Ј UTR, as well as the 3Ј HSR and 3Ј CR-1 elements, inserted between the luciferase coding sequence and the polyadenylation site. The vectors were transfected into M21 cells and were placed in normoxic or hypoxic conditions for 18 h. The luciferase expression of the control vector showed only a moderate increase in luciferase activity under hypoxia, whereas the luciferase-VPF/VEGF 3Ј UTR vector showed appreciable up-regulation ( Figure 7B ). Luciferase chimeras containing the 3Ј HSR element showed a dramatic and statistically significant increase in activity under hypoxic conditions versus normoxia, twofold with p Ͻ 0.04. The 3Ј CR-1 element, which is identical in size to the 3Ј HSR element, showed no difference in activity with hypoxia and thus serves as a size-dependent control. As described above, the 3Ј HSR element was the only part of the VPF/VEGF mRNA that showed appreciable RNA-binding activity, and thus the hypoxia-induced luciferase data correlate well with in vitro protein binding.
Distinct Proteins Bind to the AU-Rich VPF/VEGF 3 HSR Regulatory Sequence
After establishing the AU-rich 3Ј UTR sequence of human VPF/VEGF mRNA as a potential binding site for mRNA-binding proteins and as a key regulator of mRNA accumulation under hypoxia, we sought to identify specific proteins binding to this region. RNA binding/EMSA experiments were performed with normoxic and hypoxic M21 cell extracts, and the complexes were covalently cross-linked before separation on reducing SDS-polyacrylamide gels. SDS-PAGE analysis of RNA cross-linked proteins using hypoxiainduced M21 cell extracts showed hypoxia-upregulated bands of at least five distinct species. Most prominent were a doublet at 90/88-kDa, and 72-kDa, 56-kDa, and 46-kDa species ( Figure 8A ). These hypoxia-induced proteins were consistently represented in at least four independent extracts. The 40-kDa band had only moderate hypoxia induction in additional experiments. In addition, several bands were not extract dependent as indicated by a nonextract control ( Figure 8A, lane B) .
To examine the specificity of the UV-cross-linked proteins to the VPF/VEGF 3Ј HSR, a competition with cold excess 3ЈHSR RNA was performed. Increasing concentrations of 1-to 50-fold excess demonstrated increased competition for binding to the 90/88-kDa doublet and the 60-kDa bands ( Figure 8B ). The 72-kDa, 56-kDa, and 46-kDa bands did not compete as well with cold 3Ј HSR element, suggesting that they may be less specific RNA-binding proteins for this sequence. Thus, this analysis defined the 90/88-kDa doublet and the 60-kDa species as the most prominent hypoxia-induced VPF/VEGF 3Ј HSR-binding proteins. Identification and characterization of the speci- . RNA-protein complexes were detected in the presence of both RNase T1 and RNase A. Orientation-specific RNA-protein complexes were detected by using sense (S) and antisense (AS) 3Ј HSR probes and 24-h normoxic (N) and hypoxic (H) extracts. RNase-resistant complexes are indicated by arrows. Note the hypoxic induction of the faster mobility complex. (B) RNA-protein complexes competed with sense but not antisense RNA containing the 3Ј HSR sequence. A 3Ј HSR probe was used to perform RNA binding/EMSA with M21 normoxic cell extract without (Ϫ) and with a 50-fold excess of sense (S) or antisense (AS) 3Ј HSR or 3Ј 0.5-kb transcripts. K.P. Claffey et al. ficity of these protein species supports the hypothesis that they play a key role in regulating hypoxia-induced mRNA stability induced by this VPF/VEGF 3Ј HSR.
DISCUSSION
There is considerable evidence that increased release of VPF/VEGF may be critical to tumor cell survival under adverse metabolic conditions. In particular, high levels of VPF/VEGF expression have been detected in conditions characterized by tissue hypoxia, such as skin wounds, diabetic retinopathy, and solid tumors. In agreement with previous reports on human cell lines (Claffey and Robinson, 1996) , we detected a 6.5-fold increased expression of VPF/VEGF mRNA in the malignant human melanoma line M21 under hypoxic conditions.
To examine the regulatory mechanisms leading to hypoxia-induced VPF/VEGF expression in the M21 melanoma cell line, VPF/VEGF gene transcription and mRNA stability were evaluated under normoxic and hypoxic conditions. Transcription was significantly increased by hypoxia by 2.7-fold. This is in accordance with a recent report demonstrating that hypoxia-induced VPF/VEGF transcription was mediated through 5Ј flanking gene elements that contain binding sites for the hypoxia-inducible factor 1 transcriptional activator (Wang and Semenza, 1993; Minchenko et al., 1994; Levy et al., 1995; Liu et al., 1995) .
VPF/VEGF mRNA stability was found to be a significant factor in hypoxia-induced VPF/VEGF mRNA expression, demonstrating a 1.8-fold increase in M21 cells. Other similar mRNA stability experiments performed on brain-derived human gliobastoma cells revealed up to a fourfold hypoxia-induced mRNA stability (our unpublished results). The extent of VPF/ VEGF hypoxia-induced mRNA stability may be distinctly tissue or cell-type dependent. It is likely that skin-derived cells may be less responsive to hypoxia than brain cells and thus their VPF/VEGF stability control is minimized. In an effort to identify mRNA elements that might modulate mRNA stability through RNA-protein interactions, the FL VPF/VEGF mRNA as well as distinct parts were screened by a RNA-binding/EMSA system. We identified an AUrich 3Ј UTR sequence as the major region responsible for RNA-binding activity in M21 cell extracts. The RNA-binding element was found to interact with hypoxia-induced proteins. In addition, a chimeric luciferase reporter gene containing this element was significantly induced under hypoxic conditions, whereas an identical size element that is not recognized by RNA-binding proteins was unaffected. The 125-bp 3Ј UTR element, termed 3Ј HSR, was found to have a unique stem loop structure consisting of two adjacent Figure 6 . Stem loop secondary structure of the VPF/VEGF AU-rich 3Ј HSR. Secondary structure of the 125-bp 3Ј HSR sequence within the VPF/VEGF 3Ј UTR as determined by MUFOLD (Jaeger et al., 1989a,b; Zuker, 1989) . Potential RNA loop structure energies for the AU-rich regions 1 and 2 alone and the whole 3Ј HSR are indicated.
Hypoxia Regulation VPF/VEGF mRNA Stability Vol. 9, February 1998AU-rich elements. Further experiments will determine whether this structure is required for hypoxia-induced protein binding.
Five protein species of 90/88 kDa, 72 kDa, 60 kDa, 56 kDa, and 46 kDa, which bind to this AU-rich VPF/ VEGF mRNA element, were found to be hypoxia induced. However, only the 90/88 kDa and the 60 kDa were specifically competed with excess cold 3Ј HSR RNA. There is one AUUUA sequence within the VPF/ VEGF 125-bp 3Ј HSR; however, the binding proteins described here do not appear to be the same as the 15-40-kDa species of proteins that have been identified as specific binding proteins for this element, including AU-binding factor 1, AU-A/B and C proteins, AU-binding protein, and AUH factor. Interestingly, Levy et al. (1996) have recently identified a hypoxiainducible 65-kDa protein that binds to the rat VPF/ VEGF 3Ј UTR sequence, which could approximate the 60-kDa species we observe here. However, the two adjacent AU-rich sequence identified by our analysis in human VPF/VEGF 3Ј UTR is not present in the rat 3Ј UTR (Levy et al., 1996) . Purification and complete characterization of these hypoxia-induced VPF/VEGF mRNA-binding proteins will be required to evaluate their interactions with other proteins and mRNAs and their role in regulating VPF/VEGF mRNA stability.
The identification of a distinct, AU-rich HSR in the 3Ј UTR of human VPF/VEGF mRNA that is recognized by hypoxia, along with the identification of hypoxia-inducible RNA-binding proteins, is a significant step to further our understanding of the complicated mechanisms that regulate the expression of this potent angiogenic cytokine in response to oxygen stress. K.P. Claffey et al. 
